Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Trading Report for (MYL). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Market Edge
|
$10.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Mylan Inc To Buy Injectable Drugs Unit Of Strides Arcolab Ltd-Reuters
Reuters reported that Mylan Inc said it will buy a unit of Strides Arcolab Ltd for $1.6 billion. Skadden, Arps, Slate, Meagher & Flom LLP is the legal adviser, Mylan said.
Latest Developments for Mylan Inc
- Mylan Inc Reaffirms FY 2013 EPS Guidance
- Mylan Inc Issues Q1 2013 EPS Guidance Below Analysts' Estimates; Reaffirms FY 2013 Revenue And EPS Guidance-Conference Call
- Mylan Inc Issues FY 2013 Guidance In Line With Analysts' Estimates
- Mylan Inc's Mylan Laboratories Limited bags INR683-Crore (INR6.83 Billion) Order From South Africa-Business Standard
- Share this
- Link this
- Digg this
Follow Reuters